We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
.jpg)
It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines? We’ve included three industry experts who can help you get behind these stories - just let us know if you’d like us to make the introduction!
Snapshot of the story
This new collaboration will support development of the next generation of digital and diagnostic combinations in women’s health. These remote patient monitoring programs will be focused on solving issues of blood pressure-related complications, such as prenatal hypertension and using new methodologies for identifying hypertensive disorders.
Why it is notable
Industry implications
We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.
Snapshot of the story
The Mayo Clinic, in partnership with the digital health start-up Safe Health Systems, has launched a new health and connected diagnostics platform that can be used to store COVID-19 testing and vaccination data, as well as test results for sexually transmitted diseases (STDs) and other medical conditions.
Why this is notable
Industry Implications
This could be an interesting future state where individuals have health passports with a quick history of diseases and treatments, vaccinations that they carry on their phone. But how much is too much for one to have to provide as proof?
Population data analytics - could this help identify hotspots and limit the spread of the virus? Who has access to the data and how will it be used? Uncertainty around data privacy may be a limiting factor in the widespread adoption of this passport.
We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.
Snapshot of the story
Our friends at DiME and Elektra Labs have recently launched a Digital Measures Playbook to build a shared foundation for remote monitoring and digital clinical measures across research, care and public health.
Why is it notable
Digital biomarkers and measures have become a very topical area in recent years - the more the digital tools we use, the more the measurements we capture that need meaningful interpretation.
Collaboration: This playbook is the result of collaboration from across the industry, which is critical to capture multiple points of view, and to push adoption. Collaborators are Genentech, Roche Group, Elektra Labs, Koneksa, Myokardia, Sage Bionetworks, Scripps Research as well as DiME.
Industry implications
A clear message: Digital clinical measures should measure what matters most to participants, patients, and people and be defined and deployed similarly across clinical research, clinical care and public health.
What should you measure with what product, what measures are validated, where to get clinical validation for novel measures, how to use digital measures ethically, how do you bill for such measures - questions we all have, and the playbook offers an understanding of these essential concepts.
Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.
Are you a HealthXL Member? See the Full Report Here
Non-HealthXL Member? You can purchase the report HERE
Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
The integration of technology in cardiovascular disease (CVD) management holds significant potential for pharma and healthcare alike.
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
